Pfizer Immunogenic Patent Targeted In New Petition For Inter Partes Review
ALEXANDRIA, Va. — A patented immunogenic composition would have been obvious to a person of skill in the art, Sanofi Pasteur Inc. and SK Chemicals Co. Ltd. (Sanofi, collectively) assert in...To view the full article, register now.
Already a subscriber? Click here to view full article